List of Excipients in API darunavir, cobicistat, emtricitabine, and tenofovir alafenamide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing darunavir, cobicistat, emtricitabine, and tenofovir alafenamide
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Janssen Products LP | SYMTUZA | darunavir, cobicistat, emtricitabine, and tenofovir alafenamide | 59676-800 | CELLULOSE, MICROCRYSTALLINE | 2032-10-06 |
Janssen Products LP | SYMTUZA | darunavir, cobicistat, emtricitabine, and tenofovir alafenamide | 59676-800 | CROSCARMELLOSE SODIUM | 2032-10-06 |
Janssen Products LP | SYMTUZA | darunavir, cobicistat, emtricitabine, and tenofovir alafenamide | 59676-800 | FERRIC OXIDE YELLOW | 2032-10-06 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for darunavir, cobicistat, emtricitabine, and tenofovir alafenamide
Excipient focus: CELLULOSE, MICROCRYSTALLINE
darunavir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Janssen Products LP | darunavir, cobicistat, emtricitabine, and tenofovir alafenamide | 59676-800 |
>Company | >Ingredient | >NDC |
darunavir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
darunavir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Janssen Products LP | darunavir, cobicistat, emtricitabine, and tenofovir alafenamide | 59676-800 |
>Company | >Ingredient | >NDC |
darunavir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
darunavir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Janssen Products LP | darunavir, cobicistat, emtricitabine, and tenofovir alafenamide | 59676-800 |
>Company | >Ingredient | >NDC |
darunavir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants not containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
darunavir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Janssen Products LP | darunavir, cobicistat, emtricitabine, and tenofovir alafenamide | 59676-800 |
>Company | >Ingredient | >NDC |
darunavir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
darunavir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Janssen Products LP | darunavir, cobicistat, emtricitabine, and tenofovir alafenamide | 59676-800 |
>Company | >Ingredient | >NDC |
darunavir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants not containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
darunavir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Janssen Products LP | darunavir, cobicistat, emtricitabine, and tenofovir alafenamide | 59676-800 |
>Company | >Ingredient | >NDC |
darunavir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TALC
darunavir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
Janssen Products LP | darunavir, cobicistat, emtricitabine, and tenofovir alafenamide | 59676-800 |
>Company | >Ingredient | >NDC |
darunavir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
darunavir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Janssen Products LP | darunavir, cobicistat, emtricitabine, and tenofovir alafenamide | 59676-800 |
>Company | >Ingredient | >NDC |
darunavir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.